Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor

被引:22
|
作者
Montuori, N
Salzano, S
Rossi, G
Ragno, P
机构
[1] CNR, CEOS, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy
关键词
urokinase; urokinase receptor; plasminogen activation;
D O I
10.1016/S0014-5793(00)01713-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The expression of the receptor for the urokinase-type plasminogen activator (uPAR) can be regulated by several hormones, cytokines, tumor promoters, etc. Recently, it has been reported that uPAR is capable of transducing signals, el en though it is lacking a transmembrane domain and a cytoplasmatic tail. We now report that uPAR cell surface expression can be positively regulated by its ligand, uPA, in thyroid cells. The effect of uPA is independent of its proteolytic activity, since inactivated uPA or its aminoterminal fragment hare the same effects of the active enzyme. The increase of uPAR on the cell surface correlates with an increase of specific uPAR mRNA. Finally, uPA up-regulates uPAR expression also in other cell lines of different type and origin, thus suggesting that the regulatory role of uPA on uPAR expression is not restricted to thyroid cells, but it occurs in different tissues, both normal and tumoral. (C) 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:166 / 170
页数:5
相关论文
共 50 条
  • [21] β-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumors
    Hiendlmeyer, E
    Regus, S
    Wassermann, S
    Hlubek, F
    Haynl, A
    Dimmler, A
    Koch, C
    Knoll, C
    van Beest, M
    Reuning, U
    Brabletz, T
    Kirchner, T
    Jung, A
    CANCER RESEARCH, 2004, 64 (04) : 1209 - 1214
  • [22] UVB increases urokinase-type plasminogen activator receptor (uPAR) expression
    Marschall, C
    Lengyel, E
    Nobutoh, T
    Braungart, E
    Douwes, K
    Simon, A
    Magdolen, V
    Reuning, U
    Degitz, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (01) : 69 - 76
  • [23] Targeting urokinase-type plasminogen activator and its receptor for cancer therapy
    Nozaki, Shinichi
    Endo, Yoshio
    Nakahara, Hirokazu
    Yoshizawa, Kunio
    Ohara, Teruhisa
    Yamamoto, Etsuhide
    ANTI-CANCER DRUGS, 2006, 17 (10) : 1109 - 1117
  • [24] Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: Correlation with tumor associated macrophage and prognosis
    Ohba, K
    Miyata, Y
    Kanda, S
    Koga, S
    Hayashi, T
    Kanetake, H
    JOURNAL OF UROLOGY, 2005, 174 (02): : 461 - 465
  • [25] Urokinase-type plasminogen activator
    Crippa, Massimo P.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (04): : 690 - 694
  • [26] CELLULAR RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROTEIN-STRUCTURE
    BEHRENDT, N
    PLOUG, M
    RONNE, E
    HOYERHANSEN, G
    DANO, K
    PROTEOLYTIC ENZYMES IN COAGULATION, FIBRINOLYSIS, AND COMPLEMENT ACTIVATION, PART B: COMPLEMENT ACTIVATION, FIBRINOLYSIS, AND NONMAMMALIAN BLOOD COAGULATION FACTORS AND INHIBITORS, 1993, 223 : 207 - 222
  • [27] Urokinase-type plasminogen activator receptor: A beacon of malignancy?
    Drapkin, Ronny
    Clauss, Adam
    Skates, Steven
    CLINICAL CANCER RESEARCH, 2008, 14 (18) : 5643 - 5645
  • [28] Urokinase-type plasminogen activator receptor in IgA nephropathy
    Ahn, Shin-Young
    Chin, Ho Jun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2014, 29 (02): : 166 - 169
  • [29] Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator
    Jo, MJ
    Thomas, KS
    Marozkina, N
    Amin, TJ
    Silva, CM
    Parsons, SJ
    Gonias, SL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (17) : 17449 - 17457
  • [30] Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells
    Sprague, Lisa D.
    Tomaso, Herbert
    Mengele, Karin
    Schilling, Daniela
    Bayer, Christine
    Stadler, Peter
    Schmitt, Manfred
    Molls, Michael
    ONCOLOGY REPORTS, 2007, 17 (05) : 1259 - 1268